Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study

Koen Dudink*, Klasiena Bouwman, Yanqing Chen, Samuel E. DePrimo, Ernesto J. Munoz-Elias, Pim Aarts, Renske Schappin, Edwin F. Florencia, Bennie van Heeswijk, Lisette M. Prens, Hessel H. van der Zee, Errol P. Prens, Kelsey R. van Straalen, Barbara Horváth

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Scopus)
48 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry